ADA and chronic granulomatous disease: In the past years, a number of PIDs, including severe combined immune deficiencies (SCIDs: X-SCID, ADA-SCID), Wiskott–Aldrich syndrome (WAS), chronic granulomatous disease (CGD), and X-linked hyper-IgM (X-HIM) have been effectively treated by conventional gene addition-based approaches.